Inovio Pharmaceuticals (INO) 10.50 $INO
Inovio Pharmaceuticals lists in Nasdaq GS under current ticker symbol INO
M2 - Tue Sep 16, 6:13AM CDT
Vaccine company Inovio Pharmaceuticals (NasdaqGS:INO) disclosed on Monday that it will trade in the NASDAQ Global Select Market under its current ticker symbol 'INO' with immediate effect.
Inovio Pharmaceuticals (INO) Begins Trading on NASDAQ Global Select Market Exchange
PR Newswire - Mon Sep 15, 7:59AM CDT
Inovio Pharmaceuticals, Inc. (NASDAQ: INO) announced today that it has met the stringent listing criteria for the NASDAQ Global Select Market and effective today has transferred to this U.S. stock exchange from the NYSE MKT. The company will continue to trade under its current ticker symbol, "INO."
Why Inovio Pharmaceuticals Inc. Plunged By 10% in 2014
Sean Williams, The Motley Fool - Motley Fool - Fri Sep 12, 9:10AM CDT
The biotech sector, perhaps more than any other sector, is a breeding ground for large stock moves. This is because biotech stocks are predominantly valued based on their future sales potential as well as Wall Street forecasts for how many people...
Inovio Pharmaceuticals to List on NASDAQ
PR Newswire - Thu Sep 04, 8:00AM CDT
Inovio Pharmaceuticals, Inc. (NYSE MKT: INO) announced today that it has met the listing criteria for the NASDAQ Global Select Market and will transfer its U.S. stock exchange listing from the NYSE MKT to the NASDAQ Global Select Market on September 15, 2014. The company will retain its current ticker symbol, "INO."
Inovio to Present at Upcoming Investor Conferences
PR Newswire - Wed Sep 03, 7:00AM CDT
Inovio Pharmaceuticals, Inc. (NYSE MKT: INO) announced today that Inovio will present at the upcoming Rodman and Renshaw Investment Conference in New York, NY and at the Aegis Capital Healthcare and Technology Conference in Las Vegas, NV. Dr. J. Joseph Kim, Inovio's Chief Executive Officer, will provide a corporate overview of the Company and its programs at each of these events.
Technical Data on Biotech Equities -- Aegerion Pharma, ACADIA Pharma, Inovio Pharma, Curis, and Seattle Genetics
PR Newswire - Wed Aug 20, 8:20AM CDT
On Tuesday, August 19, 2014, the NASDAQ Composite ended at 4,527.51, up 0.43%, the Dow Jones Industrial Average advanced 0.48%, to finish the day at 16,919.59, and the S&P 500 closed at 1,981.60, up 0.50%. The gains were broad based as nine out of ten sectors ended the session in positive. The S&P 500 Health Care Sector Index ended the day at 726.42, up 0.66%, with the index also advancing 7.42% in the previous three months. Investor-Edge has initiated coverage on the following equities: Aegerion Pharmaceuticals Inc. (NASDAQ: AEGR), ACADIA Pharmaceuticals Inc. (NASDAQ: ACAD), Inovio Pharmaceuticals Inc. (NYSE MKT: INO), Curis Inc. (NASDAQ: CRIS), and Seattle Genetics Inc. (NASDAQ: SGEN). Free research on these five companies can be accessed at:
5 Stocks With Big Insider Trading
at The Street - Thu Aug 14, 5:00AM CDT
Insiders usually buy their own shares for one reason: They think the stock is a bargain and has tremendous upside.
Insider Trading Alert - INO, RSG And PRI Traded By Insiders
at The Street - Wed Aug 13, 9:45AM CDT
Stocks with insider trader activity include INO, RSG and PRI
Inovio Pharmaceuticals (INO) Marked As A Dead Cat Bounce Stock
at The Street - Tue Aug 12, 9:05AM CDT
Trade-Ideas LLC identified Inovio Pharmaceuticals (INO) as a "dead cat bounce" (down big yesterday but up big today) candidate
Why Inovio Pharmaceuticals (INO) Stock Is Declining Today
at The Street - Mon Aug 11, 1:55PM CDT
Inovio Pharmaceuticals (INO) shares are falling following the release of the company's second quarter earnings results.
Inovio Pharmaceuticals Reports 2014 Second Quarter Financial Results
PR Newswire - Mon Aug 11, 7:30AM CDT
Inovio Pharmaceuticals, Inc. (NYSE MKT: INO) today reported financial results for the quarter ended June 30, 2014.
INOVIO PHARMACEUTICALS, INC. SHAREHOLDER ALERT: The Law Firm of Levi & Korsinsky, LLP Launches an Investigation into Possible Breaches of Fiduciary Duty by the Board of Directors of Inovio Pharmaceuticals, Inc.
PR Newswire - Wed Aug 06, 4:16PM CDT
Levi & Korsinsky, LLP is investigating Inovio Pharmaceuticals, Inc. (NYSE: INO) in connection with possible claims of breaches of fiduciary duty.
Inovio Pharmaceuticals to Host Second Quarter 2014 Financial Results Call on August 11, 2014
PR Newswire - Fri Aug 01, 7:00AM CDT
Inovio Pharmaceuticals, Inc. (NYSE MKT: INO) announced today that it will host a conference call to report its second quarter 2014 financial results on Monday, August 11, 2014 at 9:00 AM ET. CEO Dr. J. Joseph Kim and CFO Peter Kies will discuss second quarter earnings, provide a corporate update, and participate in a live Q&A with analysts. The update will include clinical development plans for VGX-3100, Inovio's immune therapy targeting pre-cancers and cancers associated with HPV.
23.2% Return Seen to Date on SmarTrend Inovio Biomedical Call (INO)
Comtex SmarTrend(R) - Tue Jul 29, 9:46AM CDT
SmarTrend identified an Uptrend for Inovio Biomedical (AMEX:INO) on June 6th, 2014 at $9.41. In approximately 2 months, Inovio Biomedical has returned 23.16% as of today's recent price of $11.59.
What Do Short-Sellers Have Against These 3 Companies?
Sean Williams, The Motley Fool - Motley Fool - Mon Jul 28, 10:25AM CDT
The best thing about the stock market is that you can make money in either direction . Historically, stock indexes tend to trend upward over the long term. But when you look at individual stocks, you'll find plenty that lose money over the long...
This Week in Biotech: Puma Sprints, Gilead Sweeps, and Inovio Hits the Mark
Sean Williams, The Motley Fool - Motley Fool - Sat Jul 26, 12:32PM CDT
With the SPDR S&P Biotech Index up 22% over the trailing 12-month period , it's evident that investment dollars are willingly flowing into the biotech sector. Keeping that in mind, let's have a look at some of the rulings, studies, and...
Upgrade Alert for Inovio Biomedical (INO)
Comtex SmarTrend(R) - Fri Jul 25, 6:55AM CDT
Inovio Biomedical (AMEX:INO) was upgraded from Hold to Buy at Aegis today. The stock closed yesterday at $12.94 on volume of 3.6 million shares, above average daily volume of 1.7 million. Over the past year, Inovio Biomedical has traded in a range of $1.22 to $14.20 and closed yesterday at $12.98, 964% above that low. The 200-day and 50-day moving averages have moved 3.99% higher and 8.45% higher over the past week, respectively.
3 Game-Changing Stories That Shook Investors: Inovio Pharmaceuticals, Gilead Sciences, and GlaxoSmit
George Budwell, The Motley Fool - Motley Fool - Thu Jul 24, 1:05PM CDT
The health care sector exploded with major news events yesterday, fueled by second-quarter earnings, clinical trial updates, and even unexpected regulatory events. Given that the day's headlines seemed to be dominated by Puma Biotechnology 's...
The S&P 500 Closes at Yet Another All-Time Closing High on No Volume
at The Street - Wed Jul 23, 4:34PM CDT
The stock indexes closed mixed on Wednesday with the S&P 500 setting a new all-time closing high.
After Yesterday's Rally of 17.59% Shares Could Potentially Pullback
Comtex SmarTrend(R) - Wed Jul 23, 4:25PM CDT
Inovio Biomedical (AMEX:INO) traded in a range yesterday that spanned from a low of $12.00 to a high of $14.20. Yesterday, the shares gained 17.6%, which took the trading range above the 3-day high of $11.60 on volume of 12.9 million shares. Often times after large one-day gains, short term traders will seek to take profits and, as such, investors should be cautious.
Inovio Pharmaceuticals lists in Nasdaq GS under current ticker symbol INO
M2 - Tue Sep 16, 6:13AM CDT
Vaccine company Inovio Pharmaceuticals (NasdaqGS:INO) disclosed on Monday that it will trade in the NASDAQ Global Select Market under its current ticker symbol 'INO' with immediate effect.
Inovio Pharmaceuticals (INO) Begins Trading on NASDAQ Global Select Market Exchange
PR Newswire - Mon Sep 15, 7:59AM CDT
Inovio Pharmaceuticals, Inc. (NASDAQ: INO) announced today that it has met the stringent listing criteria for the NASDAQ Global Select Market and effective today has transferred to this U.S. stock exchange from the NYSE MKT. The company will continue to trade under its current ticker symbol, "INO."
Why Inovio Pharmaceuticals Inc. Plunged By 10% in 2014
Sean Williams, The Motley Fool - Motley Fool - Fri Sep 12, 9:10AM CDT
The biotech sector, perhaps more than any other sector, is a breeding ground for large stock moves. This is because biotech stocks are predominantly valued based on their future sales potential as well as Wall Street forecasts for how many people...
Inovio Pharmaceuticals to List on NASDAQ
PR Newswire - Thu Sep 04, 8:00AM CDT
Inovio Pharmaceuticals, Inc. (NYSE MKT: INO) announced today that it has met the listing criteria for the NASDAQ Global Select Market and will transfer its U.S. stock exchange listing from the NYSE MKT to the NASDAQ Global Select Market on September 15, 2014. The company will retain its current ticker symbol, "INO."
Inovio to Present at Upcoming Investor Conferences
PR Newswire - Wed Sep 03, 7:00AM CDT
Inovio Pharmaceuticals, Inc. (NYSE MKT: INO) announced today that Inovio will present at the upcoming Rodman and Renshaw Investment Conference in New York, NY and at the Aegis Capital Healthcare and Technology Conference in Las Vegas, NV. Dr. J. Joseph Kim, Inovio's Chief Executive Officer, will provide a corporate overview of the Company and its programs at each of these events.
Technical Data on Biotech Equities -- Aegerion Pharma, ACADIA Pharma, Inovio Pharma, Curis, and Seattle Genetics
PR Newswire - Wed Aug 20, 8:20AM CDT
On Tuesday, August 19, 2014, the NASDAQ Composite ended at 4,527.51, up 0.43%, the Dow Jones Industrial Average advanced 0.48%, to finish the day at 16,919.59, and the S&P 500 closed at 1,981.60, up 0.50%. The gains were broad based as nine out of ten sectors ended the session in positive. The S&P 500 Health Care Sector Index ended the day at 726.42, up 0.66%, with the index also advancing 7.42% in the previous three months. Investor-Edge has initiated coverage on the following equities: Aegerion Pharmaceuticals Inc. (NASDAQ: AEGR), ACADIA Pharmaceuticals Inc. (NASDAQ: ACAD), Inovio Pharmaceuticals Inc. (NYSE MKT: INO), Curis Inc. (NASDAQ: CRIS), and Seattle Genetics Inc. (NASDAQ: SGEN). Free research on these five companies can be accessed at:
5 Stocks With Big Insider Trading
at The Street - Thu Aug 14, 5:00AM CDT
Insiders usually buy their own shares for one reason: They think the stock is a bargain and has tremendous upside.
Insider Trading Alert - INO, RSG And PRI Traded By Insiders
at The Street - Wed Aug 13, 9:45AM CDT
Stocks with insider trader activity include INO, RSG and PRI
Inovio Pharmaceuticals (INO) Marked As A Dead Cat Bounce Stock
at The Street - Tue Aug 12, 9:05AM CDT
Trade-Ideas LLC identified Inovio Pharmaceuticals (INO) as a "dead cat bounce" (down big yesterday but up big today) candidate
Why Inovio Pharmaceuticals (INO) Stock Is Declining Today
at The Street - Mon Aug 11, 1:55PM CDT
Inovio Pharmaceuticals (INO) shares are falling following the release of the company's second quarter earnings results.
Inovio Pharmaceuticals Reports 2014 Second Quarter Financial Results
PR Newswire - Mon Aug 11, 7:30AM CDT
Inovio Pharmaceuticals, Inc. (NYSE MKT: INO) today reported financial results for the quarter ended June 30, 2014.
INOVIO PHARMACEUTICALS, INC. SHAREHOLDER ALERT: The Law Firm of Levi & Korsinsky, LLP Launches an Investigation into Possible Breaches of Fiduciary Duty by the Board of Directors of Inovio Pharmaceuticals, Inc.
PR Newswire - Wed Aug 06, 4:16PM CDT
Levi & Korsinsky, LLP is investigating Inovio Pharmaceuticals, Inc. (NYSE: INO) in connection with possible claims of breaches of fiduciary duty.
Inovio Pharmaceuticals to Host Second Quarter 2014 Financial Results Call on August 11, 2014
PR Newswire - Fri Aug 01, 7:00AM CDT
Inovio Pharmaceuticals, Inc. (NYSE MKT: INO) announced today that it will host a conference call to report its second quarter 2014 financial results on Monday, August 11, 2014 at 9:00 AM ET. CEO Dr. J. Joseph Kim and CFO Peter Kies will discuss second quarter earnings, provide a corporate update, and participate in a live Q&A with analysts. The update will include clinical development plans for VGX-3100, Inovio's immune therapy targeting pre-cancers and cancers associated with HPV.
23.2% Return Seen to Date on SmarTrend Inovio Biomedical Call (INO)
Comtex SmarTrend(R) - Tue Jul 29, 9:46AM CDT
SmarTrend identified an Uptrend for Inovio Biomedical (AMEX:INO) on June 6th, 2014 at $9.41. In approximately 2 months, Inovio Biomedical has returned 23.16% as of today's recent price of $11.59.
What Do Short-Sellers Have Against These 3 Companies?
Sean Williams, The Motley Fool - Motley Fool - Mon Jul 28, 10:25AM CDT
The best thing about the stock market is that you can make money in either direction . Historically, stock indexes tend to trend upward over the long term. But when you look at individual stocks, you'll find plenty that lose money over the long...
This Week in Biotech: Puma Sprints, Gilead Sweeps, and Inovio Hits the Mark
Sean Williams, The Motley Fool - Motley Fool - Sat Jul 26, 12:32PM CDT
With the SPDR S&P Biotech Index up 22% over the trailing 12-month period , it's evident that investment dollars are willingly flowing into the biotech sector. Keeping that in mind, let's have a look at some of the rulings, studies, and...
Upgrade Alert for Inovio Biomedical (INO)
Comtex SmarTrend(R) - Fri Jul 25, 6:55AM CDT
Inovio Biomedical (AMEX:INO) was upgraded from Hold to Buy at Aegis today. The stock closed yesterday at $12.94 on volume of 3.6 million shares, above average daily volume of 1.7 million. Over the past year, Inovio Biomedical has traded in a range of $1.22 to $14.20 and closed yesterday at $12.98, 964% above that low. The 200-day and 50-day moving averages have moved 3.99% higher and 8.45% higher over the past week, respectively.
3 Game-Changing Stories That Shook Investors: Inovio Pharmaceuticals, Gilead Sciences, and GlaxoSmit
George Budwell, The Motley Fool - Motley Fool - Thu Jul 24, 1:05PM CDT
The health care sector exploded with major news events yesterday, fueled by second-quarter earnings, clinical trial updates, and even unexpected regulatory events. Given that the day's headlines seemed to be dominated by Puma Biotechnology 's...
The S&P 500 Closes at Yet Another All-Time Closing High on No Volume
at The Street - Wed Jul 23, 4:34PM CDT
The stock indexes closed mixed on Wednesday with the S&P 500 setting a new all-time closing high.
After Yesterday's Rally of 17.59% Shares Could Potentially Pullback
Comtex SmarTrend(R) - Wed Jul 23, 4:25PM CDT
Inovio Biomedical (AMEX:INO) traded in a range yesterday that spanned from a low of $12.00 to a high of $14.20. Yesterday, the shares gained 17.6%, which took the trading range above the 3-day high of $11.60 on volume of 12.9 million shares. Often times after large one-day gains, short term traders will seek to take profits and, as such, investors should be cautious.
